LSTA:NASDAQ
Lisata Therapeutics, Inc.
၀.၉၉ US$
၀.၀၀%
(၀.၀၀) 1D
၁.၀၁ US$
arrow_upward
+၁.၈၇% (+၀.၀၁၈)todayPre-market
Closed: နို ၅, GMT-၅ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LSTA...
Mkt. cap
၁.၀၇ ကုဋေ
Avg. vol.
၉.၀၂ သောင်း
Volume
၄၀၀.၀၀
52-wk high
၅.၀၇ US$
52-wk low
၀.၉၆ US$
EPS
-၁.၆၄ US$
Beta
၁.၀၄
Shares outstanding
၁.၀၈ ကုဋေ
No. of employees
၂၁
Mkt. cap
၁.၀၇ ကုဋေ
Avg. vol.
၉.၀၂ သောင်း
Volume
၄၀၀.၀၀
52-wk high
၅.၀၇ US$
52-wk low
၀.၉၆ US$
EPS
-၁.၆၄ US$
Beta
၁.၀၄
Shares outstanding
၁.၀၈ ကုဋေ
No. of employees
၂၁
News stories
From web sources and news partners
TradingView
·
ပြီးခဲ့သည့် ၂၅ မိနစ်
Algolia Powers Orange with AI Agents for Billing Support: NYSE Content Update
Fox Business
·
ပြီးခဲ့သည့် ၃၅ မိနစ်
NASDAQ faces historic $2.5T wipeout
Bloomberg.com
·
ပြီးခဲ့သည့် ၁ နာရီ
Fast-Money Systematic Funds Stoked $2.3 Trillion Tech-Stock Rout
CNN
·
ပြီးခဲ့သည့် ၄ နာရီ
What sparked the stock market’s $2.5 trillion sell-off?
Profile
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022.
In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
About Lisata Therapeutics, Inc.
CEO-
Employees၂၁
Founded၁၉၈၀
HeadquartersBasking Ridge, နယူးဂျာစီပြည်နယ်, ယူနိုက်တက်စတိတ်
SectorHealth Care
Industry-
Websitelisata.com